Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report

Abstract Background In recent years, conversion surgery after chemotherapy has been considered a promising strategy for improving the prognosis of patients with stage IV gastric cancer. However, there are few reports on conversion gastrectomy after second-line chemotherapy. Here, we report a case of...

Full description

Bibliographic Details
Main Authors:	Kosuke Fukuda, Takaaki Arigami, Koki Tokuda, Shigehiro Yanagita, Daisuke Matsushita, Yota Kawasaki, Satoshi Iino, Ken Sasaki, Akihiro Nakajo, Mari Kirishima, Akihide Tanimoto, Hitoshi Tsubouchi, Hiroshi Kurahara, Takao Ohtsuka
Format:	Article
Language:	English
Published:	SpringerOpen 2022-04-01
Series:	Surgical Case Reports
Subjects:	Gastric cancer Second-line chemotherapy Conversion surgery
Online Access:	https://doi.org/10.1186/s40792-022-01412-x

Similar Items

Postoperative recurrence with right cervical lymph node metastasis in hepatocellular carcinoma: a case report
by: Kiyonori Tanoue, et al.
Published: (2021-12-01)

Multidisciplinary treatment of advanced or recurrent solid pseudopapillary neoplasm of the pancreas: three case reports
by: Kiyonori Tanoue, et al.
Published: (2022-01-01)

Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer
by: Keishi Okubo, et al.
Published: (2021-01-01)

Curative resection after chemotherapy and chemoradiotherapy for postoperative recurrence of pancreatic tail cancer in the abdominal wall: a case report
by: Shunya Iio, et al.
Published: (2022-05-01)

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
by: Mashiro Okunaka, et al.
Published: (2020-11-01)

Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
by: Ryu Matsumoto, et al.
Published: (2020-07-01)

Locally advanced cholangiolocellular carcinoma successfully treated with curative resection after downsizing chemotherapy: a case report
by: Yuto Hozaka, et al.
Published: (2021-01-01)

Successful subtotal gastrectomy and hepatectomy for HER2-positive gastric cancer with liver metastasis after trastuzumab-based chemotherapy: a case report
by: Yuki Hirase, et al.
Published: (2024-03-01)

Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
by: Yuto Hozaka, et al.
Published: (2021-09-01)

Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
by: Yoshifumi Hidaka, et al.
Published: (2022-06-01)

Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
by: Ken Sasaki, et al.
Published: (2020-07-01)

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
by: Annalisa Schirizzi, et al.
Published: (2023-02-01)

Fulminant Fournier’s gangrene in a patient with gastric cancer treated with ramucirumab and paclitaxel
by: Zoran Rakusic, et al.
Published: (2020-08-01)

Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
by: T. A. Titova, et al.
Published: (2018-07-01)

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis
by: Yuko Mataki, et al.
Published: (2021-03-01)

Optimizing treatment duration with ramucirumab and paclitaxel by managing chemotherapy-associated toxicity: Review of four cases
by: Man Yee Merl, et al.
Published: (2020-10-01)

Utility of the sentinel node concept for detection of lateral pelvic lymph node metastasis in lower rectal cancer
by: Shigehiro Yanagita, et al.
Published: (2017-06-01)

Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report
by: Takaaki Arigami, et al.
Published: (2020-10-01)

Malignant perivascular epithelioid cell neoplasm in the liver: report of a pediatric case
by: Tokuro Baba, et al.
Published: (2021-09-01)

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
by: Hiroshi Matsumoto, et al.
Published: (2018-01-01)

Ramucirumab: Boon or bane
by: Priya Tiwari
Published: (2016-09-01)

Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
by: Sini Li, et al.
Published: (2020-01-01)

Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
by: Tetsushi Hirahara, et al.
Published: (2019-07-01)

Case report of a lymphoepithelioma-like hepatocellular carcinoma with prominent lymphoplasmacytic infiltration
by: Hirotsugu Noguchi, et al.
Published: (2020-09-01)

Metastasis of breast cancer to the right kidney with a tumor thrombus in the inferior vena cava: a case report
by: Ayako Nagata, et al.
Published: (2022-01-01)

Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
by: N. S. Besova, et al.
Published: (2021-06-01)

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
by: Seung Tae Kim, et al.
Published: (2021-01-01)

Modified Delta-shaped Anastomosis via the Overlap Method Using Linear Staplers for Colon Cancer
by: Pramod Nepal, et al.
Published: (2021-01-01)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
by: Kosuke Hamai, et al.
Published: (2023-04-01)

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report
by: Takako Tanaka, et al.
Published: (2020-01-01)

Results of the use of ramucirumab in combination with paclitaxel or ramucirumab monotherapy as the second line treatment in patients with disseminated HER2-negative gastric or cardioesophageal junction adenocarcinoma: experience of N.N. Blokhin russian cancer research center of the ministry of health of Russia
by: N. S. Besova, et al.
Published: (2018-07-01)

Oncogenic Targets Regulated by Tumor-Suppressive <i>miR-30c-1-3p</i> and <i>miR-30c-2-3p</i>: <i>TRIP13</i> Facilitates Cancer Cell Aggressiveness in Breast Cancer
by: Reiko Mitsueda, et al.
Published: (2023-08-01)

<i>TP53</i> Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
by: Francesco Graziano, et al.
Published: (2020-07-01)

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study
by: Rosalba D’Alessandro, et al.
Published: (2022-04-01)

Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer
by: Koichiro Mandai, et al.
Published: (2017-01-01)

Clinical utility of ramucirumab in advanced gastric cancer
by: Chan MMK, et al.
Published: (2015-09-01)

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
by: Sylvie Lorenzen, et al.
Published: (2023-06-01)

The Diagnostic and Prognostic Value of a Liquid Biopsy for Esophageal Cancer: A Systematic Review and Meta-Analysis
by: Daisuke Matsushita, et al.
Published: (2020-10-01)

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study
by: Rosalba D’Alessandro, et al.
Published: (2023-04-01)

Pre-existing interstitial lung disease as a risk factor for pneumonitis associated with ramucirumab and paclitaxel in patients with gastric cancer: The impact of usual interstitial pneumonia.
by: Nobuyuki Koyama, et al.
Published: (2018-01-01)